Serologic analysis by enzyme-linked immunosorbent assay (ELISA)

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Assessing vaccine candidate efficacy requires measuring immunogenicity.
• Immunogenicity assessment involves evaluating humoral and/or cellular immune responses.
• Quantifying antibody levels against specific antigens is essential for humoral response evaluation.

Purpose of the Study:

• To highlight the importance of measuring immunogenicity for vaccine candidates.
• To introduce the enzyme-linked immunosorbent assay (ELISA) as a key method for antibody detection.

Main Methods:

• The study focuses on the enzyme-linked immunosorbent assay (ELISA) technique.
• ELISA is used to measure antibody levels against protein antigens.
• This method is applicable to monitoring responses after infection or vaccination.

Main Results:

• ELISA provides a quick and accurate method for antibody quantification.
• The assay is a long-standing tool in vaccine development.
• ELISA is routinely employed for monitoring immune responses to HIV proteins.

Conclusions:

• Accurate immunogenicity assessment is fundamental for vaccine development.
• Enzyme-linked immunosorbent assay (ELISA) is a critical tool for measuring antibody responses to protein antigens.
• ELISA facilitates the monitoring of vaccine efficacy and immune status.